Mary Ann Meyer Jones, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2022 Kelle Dr, Chesterton, IN 46304 Phone: 219-462-0909 Fax: 219-462-9910 |
Kimberly Ann Hess, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 407 W Indiana Ave, Chesterton, IN 46304 Phone: 219-763-8112 Fax: 219-763-8937 |
News Archive
Some women with endometriosis, a chronic inflammatory disease, are predisposed to ovarian cancer, and a genetic screening might someday help reveal which women are most at risk, according to a University of Pittsburgh Cancer Institute (UPCI) study, in partnership with Magee-Womens Research Institute (MWRI).
Cell Therapeutics, Inc. today announced that it met with and received feedback from the rapporteurs and the European Medicines Agency's medical reviewers regarding a proposed filing of a Marketing Authorization Application for pixantrone in the European Union to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
Recently published findings in Annals of Internal Medicine by Steven Lipshultz, M.D., Wayne State University professor and chair of pediatrics and pediatrician-in-chief at the Children's Hospital of Michigan, part of the Detroit Medical Center, and colleagues could help to reduce health care charges while also protecting childhood cancer survivors from heart ailments caused by drug therapy.
The FDA has granted Cytori Therapeutics 510(k) marketing clearance for its PureGraft™ System. Cytori will now launch the first and only device in the United States cleared for aesthetic body contouring using autologous fat. PureGraft™ allows a patient's own fat tissue to rapidly be prepared in approximately 15 minutes for re-injection back into the same patient for aesthetic contouring.
› Verified 6 days ago